← Back to Search

Mobile Neurofeedback for Chronic Lower Back Pain (NINR Trial)

N/A
Recruiting
Led By Eric Elbogen, Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
History of seizures
Rating of past week pain intensity<4 on 0-10 point scale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 3, 6, and 9

Summary

This trial aims to learn how to improve treatment for chronic low back pain. Participants will use a mobile app and headset to train their brain to relax, 4x/week for 3 months. Researchers will check in with them 6 times via phone & video.

Who is the study for?
This trial is for people who have had ongoing lower back pain for more than three months and experience it on most days over the past six months. It's not suitable for those with a history of seizures, planned pain-related surgery soon, implanted medical devices like pacemakers that could be affected by EEG/ECG, or if their pain is tied to legal claims.
What is being tested?
The study tests a mobile app and headset designed to train the brain towards relaxation as a treatment for chronic low back pain. Participants will use these tools four times weekly for three months and share feedback at set intervals throughout the study.
What are the potential side effects?
Since this intervention involves neurofeedback via an app and headset without medication, side effects may include discomfort from wearing the device or emotional responses to neurofeedback but are generally expected to be minimal.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of seizures.
Select...
My pain level in the past week was less than 4 on a scale of 0 to 10.
Select...
My lower back pain is related to a legal or compensation matter.
Select...
My pain has not severely interfered with my daily activities in the past week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 3, 6, and 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 3, 6, and 9 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain intensity
Secondary study objectives
Change in alpha brainwave (8 - 13 Hz) power as measured by EEG (electroencephalography)
Change in pain interference as measured by PROMIS (Patient-Reported Outcomes Measurement Information System)
Change in physical function as measured by speed on the 50-foot walk test

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental ConditionExperimental Treatment1 Intervention
Mobile Neurofeedback intervention arm
Group II: Control ConditionPlacebo Group1 Intervention
Sham-control arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurofeedback
2019
Completed Phase 3
~1100

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
606 Previous Clinical Trials
10,378,566 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,172,473 Total Patients Enrolled
Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,710 Total Patients Enrolled
Eric Elbogen, Ph.D.Principal InvestigatorDuke - Professor in Psychiatry and Behavioral Sciences
1 Previous Clinical Trials
183 Total Patients Enrolled

Media Library

Neurofeedback Clinical Trial Eligibility Overview. Trial Name: NCT05669027 — N/A
Chronic Lower Back Pain Research Study Groups: Experimental Condition, Control Condition
Chronic Lower Back Pain Clinical Trial 2023: Neurofeedback Highlights & Side Effects. Trial Name: NCT05669027 — N/A
Neurofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05669027 — N/A
~100 spots leftby May 2027